Clinical Trial: A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06859073) titled 'A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia' on Feb. 27.

Brief Summary: This study will evaluate an investigational drug called NNC4004-0002. "Investigational" means NNC4004-0002 has not been approved for sale/ for clinical use or for the use described in this study/ by the United States (US) Food and Drug Administration (FDA). Its use in this study is ex-perimental. This will be the first time that NNC4004-0002 will be given to human. This study will be testing the ability of the study medicine to lower serum uric acid. The main aim of this study will be to see ...